Association Between FIASMA Psychotropics and COVID-19

Published: Nov. 18, 2022, 5 p.m.

What are FIASMA psychotropics? What do they have to do with COVID-19? In this episode, we discuss a recent study that compared rates of severe illness among patients who, when admitted for COVID-19, were or were not taking a FIASMA—a functional inhibitor of acid sphingomyelinase activity.

Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.